Medefficiency, Inc.

Westminster, CO 80030
13 Employees

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $1.96MM
First Award Date 09/29/01
Most Recent Award Date 09/15/06

Key Personnel

Last Name Name Awards Contact
Jensen Dr. Jeffrey L. Jensen 7 Message

7 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/06 - 08/31/09

DESCRIPTION (provided by applicant): Between 6 and 7 million people in the United States exhibit some evidence of chronic venous insufficiency and between 600,000 and 700,000 of these individuals have or will develop venous leg ulcers that are associated with recurrent hospitalization, high health care costs, and disability. A large proportio...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/05 - 08/31/06

DESCRIPTION (provided by applicant): Between 6 and 7 million people in the United States exhibit some evidence of chronic venous insufficiency and between 600,000 and 700,000 of these individuals have or will develop venous leg ulcers that are associated with recurrent hospitalization, high health care costs, and disability. A large proportio...

Phase 2 SBIR

Agency: Defense Advanced Research Projects Agency
Topic: SB021-006
Budget: 11/03/03 - 10/30/05

The Self-Applied Field Ambulatory Exo-Splint (SAFE-Splint) is designed to facilitate soldier independence by enabling self-treatment of lower extremity injuries in combat situations. The SAFE-Splint is designed for easy and quick application, reducing ground-reactive forces (shock) and frictional forces (shearing) in the foot and ankle. Plantar ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/03 - 02/29/04

DESCRIPTION (provided by applicant): The innovation proposed is a single-unit transfer device within a customized pressure-reducing overlay. The "Patient Transfer Pressure Reducing Overlay - PtPRO" - will be engineered as the only product to provide 1) safe and non-traumatic patient transfer from one supine modality to another; 2) continuous re...

Phase 1 SBIR

Agency: Defense Advanced Research Projects Agency
Topic: SB021-006
Budget: 10/04/02 - 03/25/04

The Self-Applied Field Exo-Splint (SAFE-Splint) is designed to facilitate soldier independence by self-treating lower extremity injuries in combat situations. The SAFE-Splint is designed to be applied quickly and easily, eliminating all ground-reactive forces (shock) and all shearing forces (friction) in the foot and ankle. Theoretically, a so...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/02 - 07/31/03

Diabetic foot ulcers account for 55,000 amputations per year and are the leading cause of diabetic patient hospitalizations. Treat requires off- weighting of the foot through bed rest, wheelchair, crutches, healing sandals, modifier shoes, and/or bandaging treatments. Treatment compliance, how4ver, is difficult to maintain since diabetics with p...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/29/01 - 03/31/02

Diabetic foot complications result in over 67,000 lower extremity amputations annually and cause more hospitalizations than any other single complication of diabetes. Foot wounds precede 84% of these amputations and usually occur when patients with diabetes have peripheral neuropathy and cannot feel foot trauma from ground-reactive (shock) and s...